Gilead Sciences, Inc. vs Peloton Interactive Inc — how do they compare? Gilead Sciences, Inc. trades at $135 (market cap $164.99B), while Peloton Interactive Inc trades at $5.6 (market cap $2.42B). The key difference: Gilead Sciences, Inc. is far larger — about 68.2× Peloton Interactive Inc's market cap, and Gilead Sciences, Inc. pays a 2.47% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals.
| GILD | PTON | |
|---|---|---|
Market Cap | $164.99B | $2.42B |
Sector | Health | Consumer Cyclical |
52-Week High | $155.80 | $9.00 |
52-Week Low | $110.56 | $3.71 |
Enterprise Value | $188.06B | $2.92B |
Dividend Yield | 2.47% | — |
Trailing returns across standard periods
Latest headlines on both assets
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →